Table 1.
Baseline characteristics of study participants.
Table 2.
Biochemical characteristics of study participants.
Table 3.
Comparison of lipid parameters in fasting vs. non-fasting state (based on BMI percentiles).
Fig 1.
The percentage of abnormal lipid parameters results in fasting vs. non-fasting state [N = 289].
*Cut-off point for lipids in accordance with The National Heart, Lung and Blood Institute (NHLBI) guideline [2,6]. TC-total cholesterol; TG-triglycerides; LDL-C-low density lipoprotein cholesterol; HDL-C-high density lipoprotein cholesterol; sd-LDL-small, dense low density lipoprotein cholesterol; Apo B- apolipoprotein B; ApoAI-apolipoprotein A1; Lp(a)- lipoprotein (a).
Fig 2.
The percentage of diagnosis of dyslipidemias with the use of two lipid indices: Non-HDL-C and TG/HDL-C in fasting/non-fasting state.
non-HDL-C- non high density lipoprotein cholesterol [TC-(HDL-C)]; TG/HDL-C–triglycerides to high density lipoprotein cholesterol ratio.
Table 4.
Occurrence of abnormal lipid parameters: Comparison on the basis of BMI and fasting/non-fasting status.
Fig 3.
The occurrence of dyslipidemia according to BMI category.
BMI: body mass index.
Fig 4.
The impact of non-fasting measurements on clinical significance.
NC (No Change)- measurements in fasting and non-fasting state showed the same lipid classification; FP (False Positive);FN (False Negative);∑ (the sum of FP and FN results); TC-total cholesterol; TG-triglycerides; LDL-C-low density lipoprotein cholesterol; HDL-C-high density lipoprotein cholesterol; sd-LDL-C-small, dense low density lipoprotein cholesterol; ApoB- apolipoprotein B; ApoAI-apolipoprotein AI; Lp(a)- lipoprotein (a); non-HDL-C- non high density lipoprotein cholesterol [TC-(HDL-C)]; TG/HDL-C–triglycerides to high density lipoprotein cholesterol ratio.